Compensated Flu Vaccine Research Study
Researchers at Dana-Farber Cancer Institute have launched an innovative research study designed to help understand how a person’s immune response to the seasonal flu vaccine is affected by aging and genetics.
65-89
Years Old
Planning to Get, but Have Not Gotten, the Flu Vaccine This Year
Willing and able to travel to Dana-Farber Cancer Institute
(Free parking provided)
Fast Facts
Healthy Adults who Identify as a Minority
Study Background
Are you planning on receiving the annual influenza vaccine this year? We Need Your Help.

Influenza infection can cause big health burdens to our society. The development of an effective "universal influenza" vaccine would have great importance for public health. Researchers at the Dana-Farber Cancer Institute believe that understanding more about immune responses in older individuals may help remedy this public health challenge.

Specifically, we hope to study why some older individuals have effective antibody responses following exposure or vaccination while others do not.

Consider joining our study and support research on the flu vaccine! Compensation provided.
Additional Information